Dedicated in the private equity practice and participated in 15 due diligence and deal strategy projects in various industries including Life Science, Medtech, Retail, and Industrials.
Perform valuation analysis and build financial models to size market opportunity and forecast revenue and profit across various investment scenarios.
Developed growth strategies for a Medtech firm to achieve an additional ~$400M in annual profitability.

Performed comprehensive secondary assessments and conducted qualitative interviews with numerous key decision makers to inform asset valuation, pricing, reimbursement, and market access strategies
Coordinated and developed quantitative revenue forecast models and simulations